Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study

Table 2 Counts, treatment times and therapeutic anticoagulation of CVVHD and SLEDD in COVID-19

Data reported as counts, mean values (standard deviation) and percentages. For the calculation of the percentage of early hemodialysis termination a minimum operating time per CVVHD treatment of at least 48 h was chosen. Percentages depict portion of treatments running less than 48 h. For the calculation of the percentage of early hemodialysis termination a minimum operating time per SLEDD treatment of at least 10 h was chosen. Percentages depict portion of treatments running less than 10 h. Percentage of aPTT-, post filter calcium, or anti-factor-Xa levels in therapeutic range (UFH: aPTT ≥45 s / 1.5 times baseline; citrate: ionized Ca²⁺ post filter < 0.35 mmol/L Argatroban: aPTT ≥45 s / 1.5 times baseline; LMWH ≥0.5 IU/mL)

ISSN: 1471-2369